Medicine
Transderm Scop 1 mg/3 days transdermal patch
Transderm Scop 1 mg/3 days transdermal patch is a prescription medicine containing Scopolamine for transdermal use, marketed by Baxter Healthcare, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at controlled room temperature between 20°C to 25°C (68°F to 77°F)…
Key facts
- Active ingredient (INN)
- Scopolamine
- Brand
- Transderm Scop
- Strength
- 1 mg/3 days
- Dosage form
- Transdermal patch
- Route
- Transdermal
- Packs
- 1 patch, 4 pouches, 10 pouches and 1 more
- Marketing authorisation holder
- Baxter Healthcare
- Manufacturer
- Baxter Healthcare
- Origin register
- US FDA, United States
- Storage
- Store at controlled room temperature between 20°C to 25°C (68°F to 77°F). Store pouch(es) in an upright position.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A04AD01 Scopolamine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 December 2016
- Identifiers
- DailyMed set ID b877a694-a1d0-4280-937a-a06820b12a88NDC 10019-008Application NDA017874
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 patch in 1 pouch / 3 d in 1 patch | 10019-008-01 | Baxter Healthcare | 10 June 2026 |
| 4 pouch in 1 box / 1 patch in 1 pouch / 3 d in 1 patch | 10019-008-04 | Baxter Healthcare | 10 June 2025 |
| 10 pouch in 1 box / 1 patch in 1 pouch / 3 d in 1 patch | 10019-008-10 | Baxter Healthcare | 10 June 2025 |
| 24 pouch in 1 box / 1 patch in 1 pouch / 3 d in 1 patch | 10019-008-24 | Baxter Healthcare | 10 June 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 31 December 1979 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Scopolamine 1 mg/3 days transdermal patch.
Other strengths and forms of Scopolamine
Clinical summary
Scopolamine is an anticholinergic indicated in adults for the prevention of nausea and vomiting associated with motion sickness, among other approved uses. It is available as transdermal patches and transdermal systems. MedsAcross supplies Scopolamine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ScopolamineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Transderm Scop prescribing information (Baxter Healthcare) · U.S. National Library of Medicine, DailyMed
Need Transderm Scop 1 mg/3 days transdermal patch for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.